Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/59283
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChetcuti Zammit, Stefania-
dc.contributor.authorAzzopardi, N.Neville-
dc.contributor.authorEllul, Pierre-
dc.date.accessioned2020-08-03T10:49:51Z-
dc.date.available2020-08-03T10:49:51Z-
dc.date.issued2014-
dc.identifier.citationZammit, S. C., Azzopardi, N., & Ellul, P. (2014). Streptococcus gallolyticus bacteraemia in hepatobiliary–pancreatic and colonic pathologies. QJM: An International Journal of Medicine, 107(5), 355-361.en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/59283-
dc.description.abstractBackground: Streptococcus gallolyticus bacteraemia has been associated with several pathologies, including bacterial endocarditis and colorectal cancer. Aims: In this study, we have analysed whether Streptococcus gallolyticus bacteraemia is associated with an increased risk of hepatobiliary and colonic pathology. The association with other pathologies and the antibiotic sensitivities of Streptococcus gallolyticus were also analysed. Design: Observational retrospective study. Methods: The case notes of patients with documented Streptococcus gallolyticus bacteraemia between 2007 and 2012 at Mater Dei hospital (Malta) were reviewed. Demographic and clinical data, including co-morbidities, clinical investigations, antibiotic sensitivities and mortality were analysed. Results: A total of 42 patients (33 males, 9 females) were recruited. Two patients were pre-term infants and were therefore excluded from the study. Mean age of the cohort population studied was 72 years (SD ± 14). One-year survival rate was 62%. Gastrointestinal (colonic and hepatobiliary-pancreatic) pathologies were present in 59.5% of patients with 16% of this group having more than one gastrointestinal pathology. High incidence rates of underlying diabetes mellitus (28.6%), valvular heart disease (21.4%) and malignancies (21.4%) were noted in this study. Furthermore, we observed that 14.3% of patients had an underlying respiratory pathology. Streptococcus gallolyticus was 100% sensitive to cefotaxime and vancomycin but was highly resistant to clindamycin, erythromycin and tetracycline. Conclusions: Streptococcus gallolyticus bacteraemia is commoner in the elderly and in those with multiple underlying co-morbidities. The high incidence of gastrointestinal pathologies among patients with Streptococcus gallolyticus bacteraemia (59.5%) suggests that a thorough work-up for colonic and hepatobiliary/pancreatic pathology should be carried out in these patients.en_GB
dc.language.isoenen_GB
dc.publisherOxford University Pressen_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectStreptococcusen_GB
dc.subjectStreptococcus infectionsen_GB
dc.subjectIrritable colonen_GB
dc.subjectEndocarditisen_GB
dc.subjectBacteremiaen_GB
dc.titleStreptococcus gallolyticus bacteraemia in hepatobiliary–pancreatic and colonic pathologiesen_GB
dc.typearticleen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holderen_GB
dc.description.reviewedpeer-revieweden_GB
dc.identifier.doi10.1093/qjmed/hct261-
dc.publication.titleQJM: An International Journal of Medicineen_GB
Appears in Collections:Scholarly Works - ERCMedGen

Files in This Item:
File Description SizeFormat 
Streptococcus_gallolyticus_bacteraemia_in_hepatobiliary_pancreatic_and_colonic_pathologies.pdf221.75 kBAdobe PDFView/Open


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.